We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...
Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...
Severance season two premieres tomorrow (January 17) on Apple TV+ with episodes airing weekly on the streaming platform with a total of 10 new instalments. The trailer for season two saw Mark S ...
Trastuzumab emtansine (T-DM1) demonstrates sustained improvement in invasive disease-free survival and reduced the risk for death in human epidermal growth factor receptor 2 (HER2)-positive breast ...
The Nintendo Switch 2 has been confirmed, and we'll find out more about it in a Nintendo Direct focused on the new console that's coming in early April. In a video released a few minutes ago ...
OS Therapies’ HER2-focused immunotherapy prevented patients’ lung cancer from returning in 33% of cases, hitting the primary goal of a phase 2 trial. The therapy, dubbed OST-HER2, uses a HER2 ...
Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of recurrence and death.
Get Instant Summarized Text (Gist) Trastuzumab emtansine (T-DM1) significantly improves long-term survival in high-risk HER2-positive breast cancer patients post-surgery, reducing the risk of ...
Rapper, singer, songwriter, and actress, Eve Jihan Jeffers, who mononymously goes by her stage name Eve, recently went viral after her images of spending Christmas with her millionaire husband ...
Phesgo combines the anti-HER2 antibodies in Herceptin (trastuzumab) and Perjeta (pertuzumab) in a subcutaneous injection that takes a few minutes to deliver. At the moment, Herceptin is available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results